MTOR Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2005	Signaling by target of rapamycin proteins in cell growth control.	+	-	nl	Microbiol Mol Biol Rev 69(1):79-100 (2005)
2	2008	Rapamycin and mTOR kinase inhibitors.	+	-	nl	J Chem Biol 1(1-4):27-36 (2008)
3	2005	The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy.	+	-	nl	Cell Mol Biol Lett 10(3):479-98 (2005)
4	2007	Expanding mTOR signaling.	+	-	nl	Cell Res 17(8):666-81 (2007)
5	2009	Coordination of Ribosomal Protein and Ribosomal RNA Gene Expression in Response to TOR Signaling.	+	-	nl	Curr Genomics 10(3):198-205 (2009)
6	2009	The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents.	+	-	nl	Target Oncol 4(2):135-42 (2009)
7	2008	Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies.	+	-	nl	Mol Cancer Ther 7(6):1347-54 (2008)
8	2005	mTOR-targeted therapy of cancer with rapamycin derivatives.	+	-	nl	Ann Oncol 16(4):525-37 (2005)
9	2007	The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy.	+	-	nl	Clin Cancer Res 13(11):3109-14 (2007)
10	2007	The biology behind mTOR inhibition in sarcoma.	+	-	nl	Oncologist 12(8):1007-18 (2007)
11	2004	Upstream and downstream of mTOR.	+	-	nl	Genes Dev 18(16):1926-45 (2004)
12	2007	Defining the role of mTOR in cancer.	+	-	nl	Cancer Cell 12(1):9-22 (2007)
13	2006	TOR signaling in growth and metabolism.	+	-	nl	Cell 124(3):471-84 (2006)
14	2001	Microtubules, motors, and mRNA localization mechanisms: watching fluorescent messages move.	+	-	nl	Cell 107(6):707-10 (2001)
15	2000	TOR, a central controller of cell growth.	+	-	nl	Cell 103(2):253-62 (2000) Schmelzle T
16	2005	TOR signaling: an odyssey from cellular stress to the cell growth machinery.	+	-	nl	Curr Biol 15(4):R139-41 (2005)
17	2006	The amino acid sensitive TOR pathway from yeast to mammals.	+	-	nl	FEBS Lett 580(12):2821-9 (2006)
18	2010	Updates of mTOR inhibitors.	+	-	nl	Anticancer Agents Med Chem 10(7):571-81 (2010)
19	2006	Therapeutic targets: MTOR and related pathways.	+	-	nl	Cancer Biol Ther 5(9):1065-73 (2006)
20	2003	The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.	+	-	nl	Cancer Biol Ther 2(4 Suppl 1):S169-77 (2003)
21	2009	LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.	+	-	nl	Acta Physiol (Oxf) 196(1):65-80 (2009)
22	2009	Amino acid regulation of TOR complex 1.	+	-	nl	Am J Physiol Endocrinol Metab 296(4):E592-602 (2009)
23	2009	Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.	+	-	nl	Biochim Biophys Acta 1791(9):949-55 (2009)
24	2010	Eph receptor and mTOR pathway crosstalk: implications for cancer.	+	-	nl	Cell Cycle 9(11):2053-4 (2010)
25	2006	Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?	+	-	nl	Cell Cycle 5(21):2425-9 (2006)
26	2010	Reduced mortality and moderate alcohol consumption: the phospholipase D-mTOR connection.	+	-	nl	Cell Cycle 9(7):1291-4 (2010)
27	2008	Aging: ROS or TOR.	+	-	nl	Cell Cycle 7(21):3344-54 (2008)
28	2008	Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors.	+	-	nl	Cell Cycle 7(24):3805-9 (2008)
29	2007	All roads lead to mTOR: integrating inflammation and tumor angiogenesis.	+	-	nl	Cell Cycle 6(24):3011-4 (2007)
30	2006	The mTOR pathway in the control of protein synthesis.	+	-	nl	Physiology (Bethesda) 21(-):362-9 (2006)
31	2010	Of mice and men: therapeutic mTOR inhibition in polycystic kidney disease.	+	-	nl	J Am Soc Nephrol 21(3):390-1 (2010) Pei Y
32	2009	The role of the mammalian target of rapamycin (mTOR) in renal disease.	+	-	nl	J Am Soc Nephrol 20(12):2493-502 (2009)
33	2010	Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy.	+	-	nl	Proc Am Thorac Soc 7(1):48-53 (2010)
34	2009	mTOR signaling at a glance.	+	-	nl	J Cell Sci 122(Pt 20):3589-94 (2009)
35	2010	Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.	+	-	nl	J Biol Chem 285(19):14071-7 (2010)
36	2010	New concepts in phospholipase D signaling in inflammation and cancer.	+	-	nl	ScientificWorldJournal 10(-):1356-69 (2010)
37	2010	An emerging role for IQGAP1 in regulating protein traffic.	+	-	nl	ScientificWorldJournal 10(-):944-53 (2010)
38	2011	Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment.	+	-	nl	J Pharmacol Sci 115(4):446-52 (2011)
39	2010	Signal transduction inhibitor therapy for lymphoma.	+	-	nl	Hematology Am Soc Hematol Educ Program 2010(-):265-70 (2010)
40	2010	mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?	+	-	nl	Discov Med 9(46):173-8 (2010)
41	2010	TOR-dependent control of autophagy: biting the hand that feeds.	+	-	nl	Curr Opin Cell Biol 22(2):157-68 (2010)
42	2011	Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.	+	-	nl	J Clin Invest 121(4):1231-41 (2011)
43	2010	p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.	+	-	nl	Cold Spring Harb Perspect Biol 2(2):a001057 (2010)
44	2011	Regulation of autophagy by lysosomal positioning.	+	-	nl	Autophagy 7(8):927-8 (2011)
45	2008	The role of TOR in autophagy regulation from yeast to plants and mammals.	+	-	nl	Autophagy 4(7):851-65 (2008)
46	2010	mTOR regulation of autophagy.	+	-	nl	FEBS Lett 584(7):1287-95 (2010)
47	2004	Mammalian target of rapamycin inhibition.	+	-	nl	Clin Cancer Res 10(18 Pt 2):6382S-7S (2004)
48	2004	Mammalian target of rapamycin inhibition as therapy for hematologic malignancies.	+	-	nl	Cancer 100(4):657-66 (2004)
49	2007	Regulation of mTOR by phosphatidic acid?	+	-	nl	Cancer Res 67(1):1-4 (2007)
50	2004	Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer.	+	-	nl	Br J Cancer 91(8):1420-4 (2004)
51	2010	Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.	+	-	nl	Clin J Am Soc Nephrol 5(7):1312-29 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.